Cian McCarthy
cianpmccarthy.bsky.social
Cian McCarthy
@cianpmccarthy.bsky.social
Cardiologist | Irish | Opinions are my own
Reposted by Cian McCarthy
For symptomatic patients who’ve undergone CCTA, added knowledge gleaned from AI-CPA (@heartflow.bsky.social) changes the management strategy more than half the time, according to new data from the DECIDE registry.

tctmd.com/news/ai-base...
@cianpmccarthy.bsky.social #SCCT2025 #Cardiosky
AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry
The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.
tctmd.com
July 22, 2025 at 4:31 PM
Reposted by Cian McCarthy
SCCT is proud to announce the 2025 CTRA winner - Dr.
@cianpmccarthy.bsky.social - for his groundbreaking work on AI in atherosclerotic plaque management!

Learn more: ow.ly/EBIP50Wilxi
June 30, 2025 at 2:30 PM
Reposted by Cian McCarthy
An excellent review of the practical considerations of implementing hs-cTn - don't underestimate the time and multidisciplinary collaboration required! academic.oup.com/jalm/article... @richardbody.bsky.social @yadersandoval.bsky.social @cianpmccarthy.bsky.social
High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness
AbstractBackground. Cardiac troponin is the gold-standard biomarker for the evaluation of patients with suspected acute myocardial infarction (MI). Improve
academic.oup.com
February 12, 2025 at 8:32 PM
Reposted by Cian McCarthy
#CardioSky #MedSky 👇MUST read!

Great summary @jaccjournals.bsky.social #EIC @hmkyale.bsky.social & coauthors on @escardio.bsky.social #hypertension #GLs 👏👏

Navigating the 2024 ESC Hypertension Guidelines: What Is New, Context,...

www.sciencedirect.com/science/arti...
Navigating the 2024 ESC Hypertension Guidelines: What Is New, Context, and Future Directions
www.sciencedirect.com
January 3, 2025 at 5:30 AM